Descreening of Field Effect in Electrically Gated Nanopores

This modeling work investigates the electrical modulation characteristics of field-effect gated nanopores. Highly nonlinear current modulations are observed in nanopores with non-overlapping electric double layers, including those with pore diameters 100 times the Debye screening length. We attribute this extended field-effect gating to a descreening effect, i.e. the counter-ions do not fully relax to screen the gating potential due to the presence of strong ionic transport

THE INFLUENCE OF SALMONELLA IN PIGS PRE-HARVEST ON SALMONELLA HUMAN HEALTH COSTS AND RISK FROM PORK

Salmonellosis in people is a costly disease, much of it occurring because of food associated exposure. We develop a farm-to-fork model which estimates the pork associated Salmonella risk and human health costs. This analysis focuses on the components of the pork production chain up to the point of producing a chilled pork carcass. Sensitivity and scenario analysis show that changes that occur in Salmonella status during processing are substantially more important for human health risk and have a higher benefit/cost ratio for application of strategies that control Salmonella compared with on-farm strategies.Food Consumption/Nutrition/Food Safety,

Treatment of Metastatic Renal Cell Carcinoma

Purpose To review the treatment of metastatic renal cell carcinoma (RCC), including the use of new targeted therapies. Methods A search of MEDLINE (1966 to August 2008) and American Society of Clinical Oncology Meeting abstracts (2005 to May 2008) was preformed using the search terms bevacizumab, everolimus, interferon-alfa (IFN-α), interleukin-2 (IL-2), sorafenib, sunitinib, temsirolimus, and RCC. Articles most pertinent to the treatment of metastatic RCC are reviewed. Results The treatment of metastatic RCC has undergone a paradigm shift over the past 5 years from biologic response modifiers to new targeted therapies. Historically, response rates for the biological response modifiers, aldesleukin (IL-2), and IFN-α were approximately 15%. Recently, three targeted agents, sorafenib, sunitinib, and temsirolimus have been approved for the treatment of RCC. Additionally, bevacizumab has been investigated and shown to increase progression free survival in RCC. IL-2 remains the only agent to induce complete, durable remissions; however, many patients are not eligible for this therapy. Newer agents (sorafenib, sunitinib, and temsirolimus) have shown to be superior to IFN-α or placebo and bevacizumab combined with IFN-α has shown activity when compared to IFN-α alone. Unlike IL-2, the greatest benefit obtained with targeted therapies is in achieving stable disease (SD). Despite their benefit, targeted therapies have never been compared with each other in clinical trials and choosing the most appropriate agent remains challenging. To date, the optimal sequence or combination of treatments has not been defined; however, everolimus has recently demonstrated activity in patients progressing on targeted therapy. Conclusions IL-2 remains the most active regimen in inducing complete responses; however, its use is accompanied by substantial morbidity and is limited to those with a good performance status. Targeted therapies are also efficacious in the treatment of RCC, with the major benefit being induction of SD. Future research will better define the sequencing of therapies, as well as, explore the activity of novel combination regimens

Retrospective Evaluation of Venous Thromboembolism Prophylaxis in the Adult Cancer Population

Study objectives. Hospitalized cancer patients are at an increased risk for venous thromboembolism (VTE) and it is recommended they receive pharmacologic prophylaxis unless otherwise contraindicated. The majority of data supporting this recommendation comes from sub-group analyses and extrapolation of data gathered in general medical/surgical patients. This study seeks to assess the safety and efficacy of VTE prophylaxis in cancer patients admitted to our institution. Methods. Charts of patients 18—89 years of age receiving VTE prophylaxis with unfractionated heparin, low molecular weigh heparin, or fondaparinux while admitted to Karmanos Cancer Center between September and October 2007 were retrospectively reviewed. Risk factors for VTE were assessed and the efficacy/safety of the prophylactic agents was compared. Results. One-hundred and eighty consecutive patients were identified. The average number of risk factors for developing VTE was 3—4 per hospital admission in addition to an active cancer diagnosis. Three VTEs occurred in the heparin group with two patients experiencing a VTE during their admission and one experiencing a VTE within 1 month after discharge. Four (2.6%) patients receiving heparin had a major bleeding event. Minor bleeding occurred in 14.3, 11.5, and 22.2% of patients receiving heparin, enoxaparin, and fondaparinux, respectively. Conclusions. This retrospective study showed cancer patients are at increased risk for VTE, typically with 3—4 risk factors per admission. VTEs were uncommon; however, three patients receiving heparin experienced a VTE and four had a major bleeding event. Minor bleeding rates were similar among groups

Preparing ground states of quantum many-body systems on a quantum computer

Preparing the ground state of a system of interacting classical particles is an NP-hard problem. Thus, there is in general no better algorithm to solve this problem than exhaustively going through all N configurations of the system to determine the one with lowest energy, requiring a running time proportional to N. A quantum computer, if it could be built, could solve this problem in time sqrt(N). Here, we present a powerful extension of this result to the case of interacting quantum particles, demonstrating that a quantum computer can prepare the ground state of a quantum system as efficiently as it does for classical systems.Comment: 7 pages, 1 figur

The X10 Flare on 2003 October 29: Triggered by Magnetic Reconnection between Counter-Helical Fluxes?

Vector magnetograms taken at Huairou Solar Observing Station (HSOS) and Mees Solar Observatory (MSO) reveal that the super active region (AR) NOAA 10486 was a complex region containing current helicity flux of opposite signs. The main positive sunspots were dominated by negative helicity fields, while positive helicity patches persisted both inside and around the main positive sunspots. Based on a comparison of two days of deduced current helicity density, pronounced changes were noticed which were associated with the occurrence of an X10 flare that peaked at 20:49 UT, 2003 October 29. The average current helicity density (negative) of the main sunspots decreased significantly by about 50. Accordingly, the helicity densities of counter-helical patches (positive) were also found to decay by the same proportion or more. In addition, two hard X-ray (HXR) `footpoints' were observed by the Reuven Ramaty High Energy Solar Spectroscopic Imager (RHESSI} during the flare in the 50-100 keV energy range. The cores of these two HXR footpoints were adjacent to the positions of two patches with positive current helicity which disappeared after the flare. This strongly suggested that the X10 flare on 2003 Oct. 29 resulted from reconnection between magnetic flux tubes having opposite current helicity. Finally, the global decrease of current helicity in AR 10486 by ~50% can be understood as the helicity launched away by the halo coronal mass ejection (CME) associated with the X10 flare.Comment: Solar Physics, 2007, in pres

Immuno-Dot Blot Analysis of a Monoclonal Antibody that Blocks the Human Monocyte Response to Migration Inhibitory Factor a

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/75387/1/j.1749-6632.1987.tb29531.x.pd